010sek
-4,0 %
Date:2025-09-15Time:18:00:00Latest report:Q4-2020List:First NorthTicker:NANECH
Market Cap:31 msekEnterprise Value:31 msekNet Sales:- msekEarnings:- msekEmployees:0ISIN:SE0017133705

Ratios

10-year key figure history for NanoEcho turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for NanoEcho with index and moving average MA50 and MA200.

Stockprice:0,10
MA50:0,09
MA200:0,12
Price/MA200:-13,9 %
RSI (14):56,9
Price/MA50:13,2 %

Description

NanoEcho is active in healthcare, with a main focus in rectal cancer diagnostics. The company is active in the clinical stage, where a new diagnostic method is being developed to determine whether early rectal cancer has spread to nearby lymph nodes. The method aims to provide a correct diagnosis and individualized treatment. NanoEcho was founded in 2013 and has its headquarters in Lund.

Medical Equipment